Skip to main content
Recall Canary
Nomida Semaglutide Injection
← Back to all recalls
DRUG RECALLMODERATE

Nomida Semaglutide Injection

Nomida is recalling Semaglutide Injection 2 mg vials (NDC 84223-001-06) due to a lack of assurance of sterility.

What to do

Stop using this product immediately and contact your healthcare provider for an alternative treatment. Return the product to the place of purchase or contact New Life Pharma LLC for further instructions.

Posted
Updated
Recall No.
D-0393-2026
Agency
Firm
New Life Pharma LLC
Recall ID
98496
Status
ONGOING

Why it was recalled

Lack of Assurance of Sterility

How to identify it

Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

Where it was sold

Distributed in US-OH.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification